BIZENGRI vs TECENTRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. BIZENGRI and TECENTRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BIZENGRI	TECENTRIQ
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZENOCUTUZUMAB-ZBCO	ATEZOLIZUMAB
Manufacturer	Merus N.V.	Genentech Inc
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Lung Neoplasms, Small Cell Lung Carcinoma	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

bizengri tecentriq

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

ZENOCUTUZUMAB-ZBCO

ATEZOLIZUMAB

Manufacturer

Merus N.V.

Genentech Inc

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Lung Neoplasms, Small Cell Lung Carcinoma

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Frequently asked questions

What is the difference between Bizengri and Tecentriq?

Bizengri contains Zenocutuzumab-Zbco, while Tecentriq contains Atezolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.